Treatment with oral anticoagulant drugs restrained from patients with atrial fibrillation: An assessment in a geographically well-defined catchment area
Conclusions
This is, to our knowledge, the first study to assess the reasons for restraining the use of OAC drugs in a geographically well-defined population including all hospital-based and non-hospital-based healthcare. Applying CHA2DS2-VASc and new strategies for OAC drugs to our study data indicated that between 72 and 88% of all patients with AF are eligible for treatment with OAC drugs.
Source: European Journal of Preventive Cardiology - Category: Cardiology Authors: Andersson, P., Löndahl, M. Tags: Original scientific papers Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Heart | Hospital Management | Stroke | Study